21 – 30 of 624
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Internal mammary node irradiation in early breast cancer – target coverage and implications on dose to organs at risk
- Contribution to journal › Article
-
Mark
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
- Contribution to journal › Article
-
Mark
Comparative proton and photon treatment plans in children treated for neuroblastoma
- Contribution to journal › Article
-
Mark
Extending Human Lung Monitoring by Laser Spectroscopy From Infants Toward Adults: Initial Proof of Concept in a Porcine Lung Model
- Contribution to journal › Article
-
Mark
Overweight and Risk of Recurrence Following Neoadjuvant Chemotherapy in Breast Cancer
- Contribution to journal › Article
-
Mark
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy : Results from the prospective GHSG–NLG phase II BVB trial
- Contribution to journal › Letter
-
Mark
Serious illness conversations and quality of end-of-life care in patients with hematological malignancies-a retrospective quality improvement study
- Contribution to journal › Article
-
Mark
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
- Contribution to journal › Article
-
Mark
Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
- Contribution to journal › Scientific review
-
Mark
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
- Contribution to journal › Article
